investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Assessment of the benefits and risks of cancer treatments
Sarah Darby
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Sarah Darby
Medical Research Council (MRC)
London, United Kingdom
Related projects
Global Noncommunicable Diseases Intiatives
The Project for Provision of Equipment for Mobile Breast Cancer Diagnosis
Breast
Investigator from Multiplicom NV
Validation of diagnostic and/or prognostic miRNAs in triple-negative breast cancer
Breast
Judy Lieberman
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer
Breast
Tiffany Y Hsu
Elucidating the functions of Bud31, an essential gene in Myc-driven breast cancer
Breast
Investigator from Erasmus University Medical Center
EU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPE
Colorectum
Cervix uteri
Breast
Sylvia Richardson
Statistical Genomics and the Analysis of High Dimensional Data
Breast
Arunasree Kalle
Study the Methylation and Acetylation Status of Xi and Xa Chromosome in Normal and Cancerous Breast Epithelial Cells
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Nazneen Rahman
Using Genetics in Mainstream Medicine to Deliver Personalised Care for Cancer Patients.
Ovary
Breast